Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly [Phase 3]

View source ↗

Summary

This document covers a Phase 3 trial evaluating the safety and efficacy of paltusotine for acromegaly. Results were posted on 2026-01-13.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Paltusotine (paltusotine)

Snippet

Sponsor: Crinetics Pharmaceuticals Inc. | Conditions: Acromegaly | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-01-13